vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and BETA Technologies, Inc. (BETA). Click either name above to swap in a different company.

BETA Technologies, Inc. is the larger business by last-quarter revenue ($8.9M vs $8.0M, roughly 1.1× Baird Medical Investment Holdings Ltd). Baird Medical Investment Holdings Ltd runs the higher net margin — -142.7% vs -4902.6%, a 4759.9% gap on every dollar of revenue. Baird Medical Investment Holdings Ltd produced more free cash flow last quarter ($-3.2M vs $-209.0M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Unity Software Inc. is an American video game software development company based in San Francisco. It was founded in Denmark in 2004 as Over the Edge Entertainment and changed its name in 2007. Unity Technologies is best known for the development of Unity, a licensed game engine used to create video games and other applications.

BDMD vs BETA — Head-to-Head

Bigger by revenue
BETA
BETA
1.1× larger
BETA
$8.9M
$8.0M
BDMD
Higher net margin
BDMD
BDMD
4759.9% more per $
BDMD
-142.7%
-4902.6%
BETA
More free cash flow
BDMD
BDMD
$205.8M more FCF
BDMD
$-3.2M
$-209.0M
BETA

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
BDMD
BDMD
BETA
BETA
Revenue
$8.0M
$8.9M
Net Profit
$-11.4M
$-437.2M
Gross Margin
82.1%
69.3%
Operating Margin
-131.3%
-903.5%
Net Margin
-142.7%
-4902.6%
Revenue YoY
190.9%
Net Profit YoY
-482.5%
EPS (diluted)
$-9.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
BETA
BETA
Q3 25
$8.9M
Q2 25
$8.0M
Q3 24
$3.1M
Net Profit
BDMD
BDMD
BETA
BETA
Q3 25
$-437.2M
Q2 25
$-11.4M
Q3 24
$-75.1M
Gross Margin
BDMD
BDMD
BETA
BETA
Q3 25
69.3%
Q2 25
82.1%
Q3 24
61.2%
Operating Margin
BDMD
BDMD
BETA
BETA
Q3 25
-903.5%
Q2 25
-131.3%
Q3 24
-2381.0%
Net Margin
BDMD
BDMD
BETA
BETA
Q3 25
-4902.6%
Q2 25
-142.7%
Q3 24
-2448.3%
EPS (diluted)
BDMD
BDMD
BETA
BETA
Q3 25
$-9.83
Q2 25
Q3 24
$-1.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
BETA
BETA
Cash + ST InvestmentsLiquidity on hand
$687.6M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$789.9M
Total Assets
$77.0M
$1.1B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
BETA
BETA
Q3 25
$687.6M
Q2 25
Q3 24
$52.2M
Total Debt
BDMD
BDMD
BETA
BETA
Q3 25
Q2 25
$8.4M
Q3 24
Stockholders' Equity
BDMD
BDMD
BETA
BETA
Q3 25
$789.9M
Q2 25
$35.6M
Q3 24
$196.1M
Total Assets
BDMD
BDMD
BETA
BETA
Q3 25
$1.1B
Q2 25
$77.0M
Q3 24
Debt / Equity
BDMD
BDMD
BETA
BETA
Q3 25
Q2 25
0.24×
Q3 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
BETA
BETA
Operating Cash FlowLast quarter
$-3.2M
$-183.4M
Free Cash FlowOCF − Capex
$-3.2M
$-209.0M
FCF MarginFCF / Revenue
-40.7%
-2344.1%
Capex IntensityCapex / Revenue
0.6%
287.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
BETA
BETA
Q3 25
$-183.4M
Q2 25
$-3.2M
Q3 24
Free Cash Flow
BDMD
BDMD
BETA
BETA
Q3 25
$-209.0M
Q2 25
$-3.2M
Q3 24
FCF Margin
BDMD
BDMD
BETA
BETA
Q3 25
-2344.1%
Q2 25
-40.7%
Q3 24
Capex Intensity
BDMD
BDMD
BETA
BETA
Q3 25
287.8%
Q2 25
0.6%
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDMD
BDMD

Segment breakdown not available.

BETA
BETA

Commerical Customers$6.2M70%
United States Government$2.7M30%

Related Comparisons